-+ 0.00%
-+ 0.00%
-+ 0.00%

ADC Therapeutics: Q4 Earnings Insights

Benzinga·03/10/2026 11:32:09
Listen to the news

ADC Therapeutics (NYSE:ADCT) just disclosed its Q4 earnings on Tuesday, March 10, 2026 at 07:30 AM.

Here's a brief overview of the earnings report.

Earnings

ADC Therapeutics beat estimated earnings by 68.97%, reporting an EPS of $-0.09 versus an estimate of $-0.29.

Revenue was up $6.15 million from the same period last year.

Earnings History Overview

The company beat on EPS by $0.19 in the last quarter, resulting in a 5.7% drop share price change the following day.

Here's a look at ADC Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.38 -0.36 -0.38 -0.35
EPS Actual -0.19 -0.25 -0.22 -0.25
Revenue Estimate 16.52M 18.21M 18.15M 19.67M
Revenue Actual 16.43M 18.84M 23.03M 16.91M

To track all earnings releases for ADC Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.